CORESTEM Inc - Asset Resilience Ratio

Latest as of September 2025: 3.80%

CORESTEM Inc (166480) has an Asset Resilience Ratio of 3.80% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check 166480 strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.

Liquid Assets

₩4.30 Billion

≈ $2.92 Million USD Cash + Short-term Investments

Total Assets

₩113.27 Billion

≈ $76.76 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2014–2024)

This chart shows how CORESTEM Inc's Asset Resilience Ratio has changed over time. See net asset quality index of CORESTEM Inc to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down CORESTEM Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see CORESTEM Inc stock valuation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	₩0.00	0%
Short-term Investments	₩4.30 Billion	3.8%
Total Liquid Assets	₩4.30 Billion	3.80%

Asset Resilience Insights

Limited Liquidity: CORESTEM Inc maintains only 3.80% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

CORESTEM Inc Industry Peers by Asset Resilience Ratio

Compare CORESTEM Inc's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Ascendis Pharma AS NASDAQ:ASND	Biotechnology	0.00%
Biomarin Pharmaceutical Inc NASDAQ:BMRN	Biotechnology	0.00%
Spyre Therapeutics Inc. NASDAQ:SYRE	Biotechnology	84.34%
3SBio Inc F:83B	Biotechnology	10.64%
Soleno Therapeutics Inc NASDAQ:SLNO	Biotechnology	20.15%
Jiangxi Fushine Pharmaceutical Co Ltd SHE:300497	Biotechnology	0.02%
Novavax Inc NASDAQ:NVAX	Biotechnology	53.87%
BB Biotech AG SW:BION	Biotechnology	0.05%

Annual Asset Resilience Ratio for CORESTEM Inc (2014–2024)

The table below shows the annual Asset Resilience Ratio data for CORESTEM Inc.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	1.89%	₩2.22 Billion ≈ $1.51 Million	₩117.46 Billion ≈ $79.60 Million	-1.55pp
2023-12-31	3.44%	₩2.70 Billion ≈ $1.83 Million	₩78.59 Billion ≈ $53.26 Million	+0.14pp
2022-12-31	3.30%	₩2.59 Billion ≈ $1.76 Million	₩78.61 Billion ≈ $53.28 Million	-47.10pp
2021-12-31	50.40%	₩68.75 Billion ≈ $46.59 Million	₩136.41 Billion ≈ $92.44 Million	-15.04pp
2020-12-31	65.43%	₩93.49 Billion ≈ $63.35 Million	₩142.87 Billion ≈ $96.82 Million	+29.59pp
2019-12-31	35.85%	₩30.70 Billion ≈ $20.81 Million	₩85.65 Billion ≈ $58.04 Million	+20.72pp
2018-12-31	15.12%	₩13.50 Billion ≈ $9.15 Million	₩89.26 Billion ≈ $60.49 Million	+7.95pp
2017-12-31	7.17%	₩6.50 Billion ≈ $4.40 Million	₩90.67 Billion ≈ $61.45 Million	+0.61pp
2016-12-31	6.56%	₩5.62 Billion ≈ $3.81 Million	₩85.69 Billion ≈ $58.07 Million	+4.56pp
2015-12-31	2.00%	₩1.50 Billion ≈ $1.02 Million	₩74.95 Billion ≈ $50.80 Million	-20.51pp
2014-12-31	22.51%	₩8.10 Billion ≈ $5.49 Million	₩35.99 Billion ≈ $24.39 Million	--

pp = percentage points

About CORESTEM Inc

KQ:166480 Korea Biotechnology

Market Cap

$49.69 Million

₩73.33 Billion KRW

Market Cap Rank

#21975 Global

#1334 in Korea

Share Price

₩2610.00

Change (1 day)

-2.06%

52-Week Range

₩1060.00 - ₩4800.00

All Time High

₩32150.00